Literature DB >> 9927499

The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight.

A S Kopin1, W F Mathes, E W McBride, M Nguyen, W Al-Haider, F Schmitz, S Bonner-Weir, R Kanarek, M Beinborn.   

Abstract

Food intake and body weight are determined by a complex interaction of regulatory pathways. To elucidate the contribution of the endogenous peptide cholecystokinin, mice lacking functional cholecystokinin-A receptors were generated by targeted gene disruption. To explore the role of the cholecystokinin-A receptor in mediating satiety, food intake of cholecystokinin-A receptor-/- mice was compared with the corresponding intakes of wild-type animals and mice lacking the other known cholecystokinin receptor subtype, cholecystokinin-B/gastrin. Intraperitoneal administration of cholecystokinin failed to decrease food intake in mice lacking cholecystokinin-A receptors. In contrast, cholecystokinin diminished food intake by up to 90% in wild-type and cholecystokinin-B/gastrin receptor-/- mice. Together, these findings indicate that cholecystokinin-induced inhibition of food intake is mediated by the cholecystokinin-A receptor. To explore the long-term consequences of either cholecystokinin-A or cholecystokinin-B/gastrin receptor absence, body weight as a function of age was compared between freely fed wild-type and mutant animals. Both cholecystokinin-A and cholecystokinin-B/gastrin receptor-/- mice maintained normal body weight well into adult life. In addition, each of the two receptor-/- strains had normal pancreatic morphology and were normoglycemic. Our results suggest that although cholecystokinin plays a role in the short-term inhibition of food intake, this pathway is not essential for the long-term maintenance of body weight.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9927499      PMCID: PMC407901          DOI: 10.1172/JCI4901

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  61 in total

1.  Hunger in humans induced by MK-329, a specific peripheral-type cholecystokinin receptor antagonist.

Authors:  O M Wolkowitz; B Gertz; H Weingartner; L Beccaria; K Thompson; R A Liddle
Journal:  Biol Psychiatry       Date:  1990-07-15       Impact factor: 13.382

2.  Satiety induced by endogenous and exogenous cholecystokinin is mediated by CCK-A receptors in mice.

Authors:  S C Weatherford; F Y Chiruzzo; W B Laughton
Journal:  Am J Physiol       Date:  1992-04

3.  Differentiation of central cholecystokinin receptor binding sites using the non-peptide antagonists MK-329 and L-365,260.

Authors:  D R Hill; G N Woodruff
Journal:  Brain Res       Date:  1990-09-03       Impact factor: 3.252

4.  Reversal of the anorectic effect of (+)-fenfluramine in the rat by the selective cholecystokinin receptor antagonist MK-329.

Authors:  S J Cooper; C T Dourish; D J Barber
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

5.  Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain.

Authors:  K Kawano; T Hirashima; S Mori; Y Saitoh; M Kurosumi; T Natori
Journal:  Diabetes       Date:  1992-11       Impact factor: 9.461

6.  Increased food intake after type A but not type B cholecystokinin receptor blockade.

Authors:  R L Corwin; J Gibbs; G P Smith
Journal:  Physiol Behav       Date:  1991-07

7.  Blockade of type A, not type B, CCK receptors attenuates satiety actions of exogenous and endogenous CCK.

Authors:  T H Moran; P J Ameglio; G J Schwartz; P R McHugh
Journal:  Am J Physiol       Date:  1992-01

8.  A-71623, a selective CCK-A receptor agonist, suppresses food intake in the mouse, dog, and monkey.

Authors:  K E Asin; L Bednarz; A L Nikkel; P A Gore; A M Nadzan
Journal:  Pharmacol Biochem Behav       Date:  1992-08       Impact factor: 3.533

9.  Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas.

Authors:  S A Wank; R Harkins; R T Jensen; H Shapira; A de Weerth; T Slattery
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

10.  Effects of selective cholecystokinin antagonists L364,718 and L365,260 on food intake in rats.

Authors:  R D Reidelberger; G Varga; T E Solomon
Journal:  Peptides       Date:  1991 Nov-Dec       Impact factor: 3.750

View more
  66 in total

1.  Cholecystokinin is up-regulated in obese mouse islets and expands beta-cell mass by increasing beta-cell survival.

Authors:  Jeremy A Lavine; Philipp W Raess; Donald S Stapleton; Mary E Rabaglia; Joshua I Suhonen; Kathryn L Schueler; James E Koltes; John A Dawson; Brian S Yandell; Linda C Samuelson; Margery C Beinfeld; Dawn Belt Davis; Marc K Hellerstein; Mark P Keller; Alan D Attie
Journal:  Endocrinology       Date:  2010-06-09       Impact factor: 4.736

Review 2.  Neuroendocrine regulation of eating behavior.

Authors:  R Vettor; R Fabris; C Pagano; G Federspil
Journal:  J Endocrinol Invest       Date:  2002-11       Impact factor: 4.256

3.  Modular genetic control of sexually dimorphic behaviors.

Authors:  Xiaohong Xu; Jennifer K Coats; Cindy F Yang; Amy Wang; Osama M Ahmed; Maricruz Alvarado; Tetsuro Izumi; Nirao M Shah
Journal:  Cell       Date:  2012-02-03       Impact factor: 41.582

Review 4.  Gastrointestinal regulation of food intake.

Authors:  David E Cummings; Joost Overduin
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

Review 5.  The melanocortin system and energy balance.

Authors:  Andrew A Butler
Journal:  Peptides       Date:  2006-01-23       Impact factor: 3.750

Review 6.  Mechanisms of CCK signaling from gut to brain.

Authors:  Helen E Raybould
Journal:  Curr Opin Pharmacol       Date:  2007-10-22       Impact factor: 5.547

7.  Nutritive, Post-ingestive Signals Are the Primary Regulators of AgRP Neuron Activity.

Authors:  Zhenwei Su; Amber L Alhadeff; J Nicholas Betley
Journal:  Cell Rep       Date:  2017-12-05       Impact factor: 9.423

8.  Functional compensation between cholecystokinin-1 and -2 receptors in murine paraventricular nucleus neurons.

Authors:  Shahid Mohammad; Tomoya Ozaki; Kouhei Takeuchi; Katsuya Unno; Kurumi Yamoto; Eri Morioka; Soichi Takiguchi; Masayuki Ikeda
Journal:  J Biol Chem       Date:  2012-10-04       Impact factor: 5.157

Review 9.  The neuropathology of obesity: insights from human disease.

Authors:  Edward B Lee; Mark P Mattson
Journal:  Acta Neuropathol       Date:  2013-10-06       Impact factor: 17.088

10.  Peptide YY3-36 and 5-hydroxytryptamine mediate emesis induction by trichothecene deoxynivalenol (vomitoxin).

Authors:  Wenda Wu; Melissa A Bates; Steven J Bursian; Brenna Flannery; Hui-Ren Zhou; Jane E Link; Haibin Zhang; James J Pestka
Journal:  Toxicol Sci       Date:  2013-03-01       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.